Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis Pfizer Inc N.PFE


Primary Symbol: PFE

Healthcare
Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the... see more

Opinion & Analysis (NYSE:PFE)

Naturally Splendid (V.NSP) Enterprises Enjoys Q1 Share Price Jump

Charlotte McLeod April 3, 2015

3 Biotech Fund Choices For Strong Returns

Benzinga.com  February 9, 2015

When There's A Pullback On A Bull, Look At These Leading ETFs

Benzinga.com  November 21, 2014

Drug ETFs Attractive Buys On Pullback

Benzinga.com  October 22, 2014

Earnings Season Is The Right Prescription For Health Care ETFs

Benzinga.com  August 12, 2014

Healthcare ETFs Leading the Pack This Q2 Earnings - ETF News And Commentary

Benzinga.com  August 7, 2014

Pharma ETFs in Focus on String of Earnings Beat - ETF News And Commentary

Benzinga.com  July 30, 2014

Pharmaceutical ETFs Are Health Care Sector Standouts

Benzinga.com  July 29, 2014

Medical Device ETF In Focus As Medtronic Buys Covidien - ETF News And Commentary

Benzinga.com  June 16, 2014

ETF Outlook For Tuesday, April 29, 2014 (IHE, TAN, XRT, SOCL, TWTR)

Benzinga.com  April 29, 2014

3 Ways To Profit From Merger Activity In The Pharmaceutical Sector

Benzinga.com  April 25, 2014

Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)

Benzinga.com  April 22, 2014

Biotechs Struggling To Find A Bottom

Benzinga.com  April 8, 2014

Despite S&P 500's New High, Stocks Face Challenges

Benzinga.com  April 1, 2014

Finding a safer route to higher yields

Marc Lichtenfeld January 23, 2014

This China sector is ramping up

Larsen Kusick September 18, 2010

Big Pharma has a big problem and merger mania is heating up

Marc Lichtenfeld July 29, 2010

Stock market myth: share buybacks work

Andrew Mickey October 29, 2008